Chemotherapy Effects on Brain Function in Breast Cancer
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
Recruiting
Observational Study
Cancer Related Cognitive Difficulties
Breast Cancer Female
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 21 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- University of Rochester · Other
Who this trial is looking for
This trial is looking for women with breast cancer starting chemotherapy and women without cancer for comparison. Participants will take part in cognitive tests and provide blood samples over about 5 months.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with invasive non-metastatic breast cancer.
- I am scheduled to start chemotherapy with Adriamycin and Cytoxan.
- I can speak and read English.
- I am 21 years or older.
- I give written informed consent.
You may not be able to join if
- I am currently hospitalized for a psychiatric illness.
- I have a neurodegenerative disease.
- I have any Central Nervous System disease.
- I am scheduled to receive radiation treatment during chemotherapy.
- I am colorblind.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Study is enrolling newly diagnosed breast cancer patients about to start chemotherapy and age-matched control participants. The investigator is trying to better understand the prevalence of cognitive difficulties in cancer patients receiving chemotherapy compared to the general population as well as what biological mechanisms may play a role in the development of these difficulties. Patients will …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria, Breast Cancer Patient Participants:
* Females with a diagnosis of invasive non-metastatic breast cancer (stage I-IIIC)
* Scheduled to begin a course of chemotherapy with Adriamycin and Cytoxan
* Chemotherapy naïve
* Able to speak and read English
* 21 years or older
* Give writt…
Contacts